<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00832247</url>
  </required_header>
  <id_info>
    <org_study_id>CELTHEP-02</org_study_id>
    <nct_id>NCT00832247</nct_id>
  </id_info>
  <brief_title>Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis</brief_title>
  <acronym>CELTHEP-02</acronym>
  <official_title>Phase 1 Study of Autologous Bone Marrow Mononuclear Cells Infusion in Peripheral Vein in Liver Cirrhosis Due to Hepatitis C Virus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Financiadora de Estudos e Projetos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oswaldo Cruz Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase I clinical study to evaluate feasibility, safety and kinetics of cellular
      therapy with autologous bone marrow-derived mononuclear cells (BMMC) in patients with liver
      cirrhosis due to virus C hepatitis. Another aim is to study liver tissue changes induced by
      the BMMC presence. All the patients have moderate liver disfunction and will be submitted to
      a liver biopsy before BMMC injection. The cells will be labeled with 99mTc and infused
      through a peripheral vein. Scintigraphy will be performed 24 hours after infusion.

      Patients will be submitted to frequent clinical, laboratorial and image evaluation during a
      one-year follow-up. A second liver biopsy will be done in the 3rd month after infusion to
      check histological, cellular and molecular evolutive changes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver function worsening</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Liver related mortality</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatocellular carcinoma development accessed by ultrasound and CT scan</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMMC kinetics accessed by total body scintigraphy</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver tissue changes evaluated by histopathology analysis and molecular biology</measure>
    <time_frame>10 weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Liver Cirrhosis Due to Virus C Chronic Hepatitis</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Autologous bone marrow mononuclear cells infusion</intervention_name>
    <description>At least 100.000.000 autologous BMMC will be infused in a peripheral vein once suspended in albumine during 10 minutes</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic virus C hepatitis

          -  Liver cirrhosis

          -  Moderate liver disfunction

        Exclusion Criteria:

          -  Malignant disease

          -  Pregnancy

          -  Significant comorbidity

          -  Portal vein thrombosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guilherme FM Rezende, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guilherme FM Rezende, MD PhD</last_name>
    <phone>55-21-99976292</phone>
    <email>g.rezende@superig.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>André Torres, MD</last_name>
    <phone>55-21-78568495</phone>
    <email>torres.alm@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitário Clementino Fraga Filho</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>21914-913</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2009</study_first_submitted>
  <study_first_submitted_qc>January 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2009</study_first_posted>
  <last_update_submitted>January 29, 2009</last_update_submitted>
  <last_update_submitted_qc>January 29, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Guilherme Ferreira da Motta Rezende</name_title>
    <organization>Federal UNiversity of Rio de Janeiro</organization>
  </responsible_party>
  <keyword>Hepatitis C</keyword>
  <keyword>Cirrhosis</keyword>
  <keyword>Stem cell</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

